Clinical Trial Update: Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating megestrol acetate for weight loss in severe chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Rottapharm Spain | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED